EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bauer, D. C
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bauer, D. C
Topic Collections
Right arrow EBM Diagnosis
Evidence-Based Medicine 2000; 5:29
© 2000 Evidence-Based Medicine

Review: sensitive thyrotropin testing in unselected inpatients has low diagnostic accuracy

Attia J, Margetts P, Guyatt G.Diagnosis of thyroid disease in hospitalized patients. A systematic review.Arch Intern Med 1999 Apr 12;159:658–65[Abstract/Free Full Text]

Questions In hospitalised patients with non-thyroidal illness (NTI), are clinical signs and symptoms useful for predicting overt thyroid disease? Is the sensitive thyrotropin (thyroid-stimulating hormone [sTSH]) assay useful for detecting thyroid disease?

Data sources
Studies were identified by searching Medline with the following 2 groups of terms: thyroid diseases, cohort studies, and signs or symptoms; and thyrotropin, hospitalised or medical or inpatient, and sensitivity or specificity. Bibliographies of relevant articles were scanned. Searches were done by 2 different researchers.

Study selection
English-language studies were selected if they enrolled >50 patients. Studies on signs or symptoms were included if they reported sufficient information to allow positive likelihood ratios (+LRs) to be calculated. Studies on sTSH assays were selected if they included patients who were acutely ill or hospitalised with an NTI and if they used second- or third-generation sTSH assays and follow-up after resolution of NTI as reference standards.

Data extraction
2 reviewers independently extracted data on patients, study type, diagnostic standard, follow-up, and number of signs and symptoms. +LRs were calculated. The quality of study methods was assessed by using 3 criteria: follow-up of patients with normal and . . . [Full text of this article]

Douglas C Bauer, MD

University of California at San Francisco San Francisco, California, USA







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd.